These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28596426)

  • 21. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement.
    Kim V; Aaron SD
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30237306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry.
    Dhar R; Singh S; Talwar D; Mohan M; Tripathi SK; Swarnakar R; Trivedi S; Rajagopala S; D'Souza G; Padmanabhan A; Baburao A; Mahesh PA; Ghewade B; Nair G; Jindal A; Jayadevappa GDH; Sawhney H; Sarmah KR; Saha K; Anantharaj S; Khanna A; Gami S; Shah A; Shah A; Dutt N; Garg H; Vyas S; Venugopal K; Prasad R; Aleemuddin NM; Karmakar S; Singh V; Jindal SK; Sharma S; Prajapat D; Chandrashekaria S; McDonnell MJ; Mishra A; Rutherford R; Ramanathan RP; Goeminne PC; Vasudev P; Dimakou K; Crichton ML; Jayaraj BS; Kungwani R; Das A; Sawhney M; Polverino E; Torres A; Gulecha NS; Shteinberg M; De Soyza A; Mangala A; Shah P; Chauhan NK; Jajodia N; Singhal A; Batra S; Hasan A; Limaye S; Salvi S; Aliberti S; Chalmers JD
    Lancet Glob Health; 2019 Sep; 7(9):e1269-e1279. PubMed ID: 31402007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of bronchiectasis and chronic suppurative lung disease in indigenous children and adults from rural and remote Australian communities.
    Chang AB; Grimwood K; Maguire G; King PT; Morris PS; Torzillo PJ
    Med J Aust; 2008 Oct; 189(7):386-93. PubMed ID: 18837683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.
    Shoemark A; Cant E; Carreto L; Smith A; Oriano M; Keir HR; Perea L; Canto E; Terranova L; Vidal S; Moffitt K; Aliberti S; Sibila O; Chalmers JD
    Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 31151955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [DIAGNOSIS AND TREATMENT OF BRONCHIECTASIS: POSITION PAPER OF THE ISRAELI PULMONOLOGY SOCIETY AND THE ISRAELI PEDIATRIC PULMONOLOGY SOCIETY].
    Shteinberg M; Hardak E; Koslow M; Prais D; Cohen-Cymberkno M; Shoseyov D; Dagan A; Adir Y; Shitrit D
    Harefuah; 2018 Feb; 157(2):117-121. PubMed ID: 29484869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of bronchiectasis in adults.
    Visser SK; Bye P; Morgan L
    Med J Aust; 2018 Aug; 209(4):177-183. PubMed ID: 30107772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial.
    O'Grady KA; Grimwood K; Cripps A; Mulholland EK; Morris P; Torzillo PJ; Wood N; Smith-Vaughan H; Revell A; Wilson A; Van Asperen P; Richmond P; Thornton R; Rablin S; Chang AB
    Trials; 2013 Sep; 14():282. PubMed ID: 24010917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity].
    Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):254-261. PubMed ID: 30955282
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004403. PubMed ID: 16625602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a respiratory rehabilitation exercise training package in hospitalized elderly patients with acute exacerbation of COPD: a randomized control trial.
    Liao LY; Chen KM; Chung WS; Chien JY
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1703-9. PubMed ID: 26345529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.
    Chang AB; Grimwood K; Robertson CF; Wilson AC; van Asperen PP; O'Grady KA; Sloots TP; Torzillo PJ; Bailey EJ; McCallum GB; Masters IB; Byrnes CA; Chatfield MD; Buntain HM; Mackay IM; Morris PS
    Trials; 2012 Aug; 13():156. PubMed ID: 22937736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical perspectives in bronchiectasis management.
    Chaudary N; Fadell F; Garcia B; Haumschild R; Johnson MM; Keith RC; Maselli DJ; Solomon G; Winthrop K
    Am J Manag Care; 2024 Aug; 30(4 Suppl):S52-S59. PubMed ID: 39133221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research Registry.
    Basavaraj A; Choate R; Addrizzo-Harris D; Aksamit TR; Barker A; Daley CL; Anne Daniels ML; Eden E; DiMango A; Fennelly K; Griffith DE; Johnson MM; Knowles MR; Metersky ML; Noone PG; O'Donnell AE; Olivier KN; Salathe MA; Schmid A; Thomashow B; Tino G; Winthrop KL
    Chest; 2020 Oct; 158(4):1376-1384. PubMed ID: 32622820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhaled aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a
    Crichton ML; Lonergan M; Barker AF; Sibila O; Goeminne P; Shoemark A; Chalmers JD
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32265309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials.
    Leidy NK; Murray LT; Monz BU; Nelsen L; Goldman M; Jones PW; Dansie EJ; Sethi S
    Respir Res; 2014 Oct; 15(1):124. PubMed ID: 25287629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definitions of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Exacerbation: A Modified Delphi Survey.
    Park YB; Lee JH; Ra SW; Park HY; Jung JY; Kang YA; Rhee CK; Kim DK; Yoo KH; Hwang YI; Lim SY; Lee JS; Jo KW; Oh YM
    Tuberc Respir Dis (Seoul); 2023 Jul; 86(3):196-202. PubMed ID: 37254490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.
    Muñoz G; de Gracia J; Buxó M; Alvarez A; Vendrell M
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29326318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
    Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM; Beier J; Candler H; Wittig T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemoptysis in adults with bronchiectasis: correlation with disease severity and exacerbation risk].
    Guan WJ; Yuan JJ; Gao YH; Li HM; Zhong NS; Chen RC
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jan; 40(1):16-23. PubMed ID: 28100357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.